相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial
Henan Xin et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Trends in the disease burden of HBV and HCV infection in China from 1990-2019
Tingting Yue et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study
Jun Cheng et al.
INFECTIOUS DISEASES OF POVERTY (2020)
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
S. Swindells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
D. Menzies et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study
Lei Gao et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study
Lei Gao et al.
LANCET INFECTIOUS DISEASES (2017)
Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury
Wan Soo Kim et al.
BMC INFECTIOUS DISEASES (2016)
Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study
Lei Gao et al.
LANCET INFECTIOUS DISEASES (2015)
Treatment for Preventing Tuberculosis in Children and Adolescents A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid
M. Elsa Villarino et al.
JAMA PEDIATRICS (2015)
Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis
Nino Lomtadze et al.
PLOS ONE (2013)
Treatment of latent infection with Mycobacterium tuberculosis: update 2010
C. C. Leung et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Timothy R. Sterling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)